Crossmark

Evaluation of the clinical and biochemical efficacy of erbium, chromium:ytrium-scandium-gallium-garnet (ER,CR:YSGG) laser treatment in periodontitis

Published Online: 2020-03-25

Published Print: 2020-09

Authors

Sezen, Dilara

Hatipoğlu, Mükerrem

Üstün, Kemal
Funding

Funding for this research was provided by:

Akdeniz Üniversitesi (TDH-2018-3048)
License Information

Text and Data Mining valid from 2020-03-25

Version of Record valid from 2020-03-25
More Information

Article History

Received: 21 October 2019

Accepted: 26 February 2020

First Online: 25 March 2020

Compliance with ethical standards

:

: There are no conflicts of interest related to this study.

: This clinical trial was approved by the Akdeniz University Faculty of Medicine Clinical Research Ethics Committee (number: 70904504/153) and the Republic of Turkey Ministry of Health, Turkish Medicines, and Medical Devices Agency (number:71146310-511.06-E.204274).

: All volunteers included in the study were informed about the purpose and method of the study and signed an informed consent form approved by the Republic of Turkey Ministry of Health, Turkish Medicines, and Medical Devices Agency (number: 71146310-511.06-E.204274).All procedures performed in the present study were in accordance with the Helsinki declaration.

Document is current